Colon Cancer Research

Colon cancer, also known as colorectal cancer, is a type of cancer that begins in the colon or rectum. It is one of the most common cancers worldwide and can occur in people of any age, although it is more common in those over the age of 50.

Symptoms of colon cancer can include changes in bowel habits, rectal bleeding, abdominal pain or cramping, and unexplained weight loss. However, many people with colon cancer may not experience any symptoms until the cancer has progressed to a later stage. Preventive measures for colon cancer include maintaining a healthy diet and lifestyle, regular exercise, and avoiding tobacco and excessive alcohol consumption. Increased awareness and early detection through screening can significantly reduce the impact of colon cancer on individuals and society.

Treatment options for colon cancer depend on the stage of the cancer and can include surgery, chemotherapy, radiation therapy, or a combination of these treatments. Early detection is important, as it can improve the chances of successful treatment and survival. Screening tests such as colonoscopies and stool tests can help detect colon cancer at an early stage before symptoms develop.

At Gillies McIndoe Research Institute, our research into the causes and treatment of colon cancer has a focus on developing new targeted drug therapies to improve patient outcomes. We are conducting experiments utilising colon organoids and cell cultures to investigate the potential benefits of repurposed drugs that target pathways that are critical to the growth and development of colon cancer to improve patient outcomes.